Buy more Synthroid and Save more.

Abbott Laboratories plans to submit an NDA for Synthroid (levothyroxine sodium, USP), a treatment for hypothyroidism. The company recently obtained rights to the product through its acquisition of BASF Pharma, which includes Knoll Pharmaceutical Co.

Related Results

Bioequivalence of generic Synthroid questionedSynthroid - S…